Приклади вживання Quality risk Англійська мовою та їх переклад на Українською
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
Quality risk management(QRM).
Quality risk management: ICH Q9.
The level of effort, formality& documentation of the quality risk management process should be commensurate with the level of risk. .
Quality risk management should be integrated into existing operations and documented appropriately.
As outlined in the introduction, appropriate use of quality risk management does not obviate industry's obligation to comply with regulatory requirements.
Quality risk assessments begin with a well-defined problem description or risk question.
It is important to note that no one tool orset of tools is applicable to every situation in which a quality risk management procedure is used.
Q9- Quality Risk Management.
The purpose of this annex is to provide a general overview of andreferences for some of the primary tools that might be used in quality risk management by industry and regulators.
ICH Q9: Quality Risk Management.
In addition, the importance of quality systems has been recognized in the life sciences industry,and it is becoming evident that quality risk management is a valuable component of an effective quality system.
Proactive quality risk prediction, identification, and prevention.
Between the industry and regulatory authorities, communication concerning quality risk management decisions might be effected through existing channels as specified in regulations and guidances.
Quality risk management activities are usually, but not always, undertaken by interdisciplinary teams.
In these circumstances, it might be agreed that an appropriate quality risk management strategy has been applied and that quality risk is reduced to a specified(acceptable) level.
Quality risk management is a process that supports science-based and practical decisions when integrated into quality systems(see Annex II).
Annex II provides examples of situations in which the use of the quality risk management process might provide information that could then be used in a variety of pharmaceutical operations.
Quality Risk Management should include systematic processes designed to organise, facilitate and improve science-based decision making with respect to risk. .
While regulatory decisions will continue to be taken on a regional basis,a common understanding and application of quality risk management principles could facilitate mutual confidence and promote more consistent decisions among regulators on the basis of the same information.
The outcome of the Quality Risk Management process should be the basis for determining the extent of technical and organisational measures required to control risks for cross-contamination.
Although there are some examples of the use of quality risk management in the pharmaceutical industry today, they are limited and do not represent the full contributions that risk management has to offer.
Appropriate use of quality risk management can facilitate but does not obviate industry's obligation to comply with regulatory requirements and does not replace appropriate communications between industry and regulators.
However, a well-considered conservative investment strategy based on quality risk management and many years of experience with the"OTP Group" and professionalism of service companies allows us to talk about the reliability of the"OTP Pension" fund.
However, effective quality risk management can facilitate better and more informed decisions, provide regulators with greater assurance of a company's ability to deal with potential risks, and might affect the extent and level of direct regulatory oversight.
It specifically provides guidance on the principles and some of the tools of quality risk management that can enable more effective and consistent risk-based decisions, by both regulators and industry, regarding the quality of drug substances and drug products across the product lifecycle.
Proactive quality risk prediction, identification, and prevention.
However, effective quality risk management can facilitate better and more informed decisions, provide regulators with greater assurance of a company's ability to deal with potential risks, and might affect the extent and level of direct regulatory oversight.